Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma
暂无分享,去创建一个
Adam B. Olshen | Mark E. Robson | Kenneth Offit | Oscar Lin | Narciso Olvera | Douglas A. Levine | A. Olshen | A. Viale | K. Offit | D. Levine | J. Boyd | R. Barakat | M. Robson | Narciso Olvera | O. Lin | M. Leitao | R. Soslow | F. Bogomolniy | Richard R. Barakat | Jeff Boyd | Bhavana Pothuri | C. Arroyo | B. Pothuri | Mario M. Leitao | Agnès Viale | Crispinita Arroyo | Faina Bogomolniy | Robert A. Soslow
[1] K. Mittal. Morphologic precursors of ovarian epithelial tumors. , 1993, Obstetrics and gynecology.
[2] A. Magliocco,et al. A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors , 2003, Cancer.
[3] K. Kinzler,et al. Targeted inactivation of p53 in human cells does not result in aneuploidy. , 2002, Cancer research.
[4] R. Drapkin,et al. New insights into the pathogenesis of serous ovarian cancer and its clinical impact. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] L. Dubeau. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? , 1999, Gynecologic oncology.
[6] J Gil,et al. Ovarian dysplasia in prophylactic oophorectomy specimens , 1999, Cancer.
[7] R. Scully,et al. Early de novo ovarian carcinoma. A study of fourteen cases , 1994, Cancer.
[8] A S Whittemore,et al. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. , 2000, Journal of the National Cancer Institute.
[9] C. Lengauer. Aneuploidy and genetic instability in cancer. , 2005, Seminars in cancer biology.
[10] Radisavljevic Sv. The pathogenesis of ovarian inclusion cysts and cystomas. , 1977 .
[11] Douglas A. Hosack,et al. Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.
[12] D. Livingston,et al. In search of the tumour-suppressor functions of BRCA1 and BRCA2 , 2000, Nature.
[13] Dimitris Kletsas,et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.
[14] J. Boyd,et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. , 2000, JAMA.
[15] P. Kenemans,et al. Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause. , 2004, American journal of obstetrics and gynecology.
[16] R. Barakat. Principles and Practice of Gynecologic Oncology , 2009 .
[17] R. Scully. Pathology of ovarian cancer precursors , 1995, Journal of cellular biochemistry. Supplement.
[18] J. Boyd,et al. Mutation and expression of the TP53 gene in early stage epithelial ovarian carcinoma. , 2004, Gynecologic oncology.
[19] K. Offit,et al. Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers. , 1998, Cancer research.
[20] S. Sen,et al. Aneuploidy and cancer , 2000, Current opinion in oncology.
[21] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[22] Kathleen R. Cho,et al. Surface Epithelial Tumors of the Ovary , 2011 .
[23] J. Levine,et al. Surfing the p53 network , 2000, Nature.
[24] B. Werness,et al. Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. , 1999, Human pathology.
[25] T. Davis,et al. Pcp1p, an Spc110p-related calmodulin target at the centrosome of the fission yeast Schizosaccharomyces pombe. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[26] E. Salmon,et al. E-MAP-115 (ensconsin) associates dynamically with microtubules in vivo and is not a physiological modulator of microtubule dynamics. , 1999, Journal of cell science.
[27] J. Boyd,et al. Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer , 2002, Current opinion in obstetrics & gynecology.
[28] T. Flotte,et al. Prognostic significance of DNA content in epithelial ovarian cancer. , 1994, Gynecologic oncology.
[29] T. Hunter,et al. PRC1 is a microtubule binding and bundling protein essential to maintain the mitotic spindle midzone , 2002, The Journal of cell biology.
[30] Ie-Ming Shih,et al. The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory , 2010, The American journal of surgical pathology.
[31] Duane A. Compton,et al. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism , 2010, The Journal of cell biology.
[32] T. Kreis,et al. Identification and molecular characterization of E-MAP-115, a novel microtubule-associated protein predominantly expressed in epithelial cells , 1993, The Journal of cell biology.
[33] J Gil,et al. Characterization of ovarian dysplasia by interactive morphometry , 1989, Cancer.
[34] Martin A. Nowak,et al. The significance of unstable chromosomes in colorectal cancer , 2003, Nature Reviews Cancer.
[35] P. Duesberg,et al. Multistep Carcinogenesis: A Chain Reaction of Aneuploidizations , 2003, Cell cycle.
[36] Martin A Nowak,et al. Can chromosomal instability initiate tumorigenesis? , 2005, Seminars in cancer biology.
[37] C. Perez,et al. Principles and Practice of Gynecologic Oncology , 1992 .
[38] T. Davis,et al. Identification of a human centrosomal calmodulin-binding protein that shares homology with pericentrin. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] T. Ørntoft,et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.
[40] S. Radisavljevic. The Pathogenesis of Ovarian Inclusion Cysts and Cystomas , 1977, Obstetrics and gynecology.
[41] P. Leung,et al. Ovarian surface epithelium: biology, endocrinology, and pathology. , 2001, Endocrine reviews.
[42] B. Werness,et al. p53, c-erbB, and Ki-67 expression in ovaries removed prophylactically from women with a family history of ovarian cancer. , 1999, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[43] M. Wells,et al. p53 protein expression in putative precursor lesions of epithelial ovarian cancer , 1995, Histopathology.
[44] F. Penault-Llorca,et al. Prophylactic oophorectomy , 2003, Cancer.
[45] D. Ward,et al. Diagnostic Markers for Early Detection of Ovarian Cancer , 2008, Clinical Cancer Research.
[46] V. Livolsi. Blaustein's Pathology of the Female Genital Tract, 5th ed , 2002 .
[47] A. Al-Niaimi,et al. Epithelial ovarian cancer. , 2012, Obstetrics and gynecology clinics of North America.
[48] S. Cha,et al. Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survival. , 1996, American journal of obstetrics and gynecology.
[49] T. Rollason. Blaustein’s Pathology of the Female Genital Tract , 2003, Springer New York.
[50] Elise C. Kohn,et al. Proteomics as a Tool for Biomarker Discovery , 2007, Disease markers.